Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma

Cancer

Volumn 77, Issue 10, 1996, Pages 2117-2122

  Tavio, Marcello ^a   Vaccher, Emanuela ^a   Antinori, Andrea ^b   Ammassari, Adrians ^b   Cusini, Marco ^c   Fasan, Marco ^d   Accurso, Vincenzo ^e   Garavelli, Luigi P ^f   Repetto, Lazzaro ^g   Tirelli, Umberto ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e OSPEDALE DEGLI INFERMI   (Italy)

^f Ospedale Civile   (Italy)

^g Division of Medical Oncology   (Italy)

Author keywords

ABVi; AIDS; chemotherapy; hematopoietic growth factors; HIV infection; Kaposi's sarcoma; Kaposi's sarcoma survival

Indexed keywords

BLEOMYCIN; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; VINDESINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DRUG RESPONSE; FEMALE; GRANULOCYTOPENIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ITALY; KAPOSI SARCOMA; MALE; MULTICENTER STUDY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGRANULOCYTOSIS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; DOXORUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SARCOMA, KAPOSI; SURVIVAL ANALYSIS; VINDESINE;

EID: 15844421721     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960515)77:10<2117::AID-CNCR23>3.0.CO;2-X     Document Type: Article

References (21)

1. Rutherford GW, Schwarcz SK, Lemp GF, Barnhart JL, Rauch KJ, Warner WL, et al. The epidemiology of AIDS-related Kaposi's Sarcoma in San Francisco. J Infect Dis 1989; 159(3): 569-72.
2. Serraino D, Franceschi S, Tirelli U, Monfardini S. The epidemiology of acquired immunodeficiency syndrome and associated tumors in Europe. Ann Oncol 1992;3:595-603.
3. Tirelli U, Vaccher E, Lazzarin A, Errante D, Alessi E, Crosato I, et al. Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug users as the main group affected by HIV infection. Ann Oncol 1991;2:373-6.
4. Gill PS, Axil B, Colletti P. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am J Med 1989;87:57-61.
5. Laubenstein LJ, Krigel RL, Odajnyk CM, Hymes KB, Friedman-Kien A, Wernz JC, et al. Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin and vincristine. J Clin Oncol 1984;2:1115-20.
6. Volberding PA, Abrams DI, Conant M. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:335.
7. Mintzer D, Real F, Jovino F. Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with acquired immunodeficiency syndrome. Ann Intern Med 1985;102:200.
8. Kaplan L, Abrams D, Volberding P. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer Treat Rep 1986;70:1121.
9. Gill P, Rarick M, Bernstein-Singer M, Harb M, Espina BM, Shaw V, et al. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 1990;13(4):315-9.
10. Gompels MM, Hill A, Jenkins P, Peters B, Tomlinson D, Harris JRW, et al. Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS 1992;6(10):1175-80.
11. Gill PS, Rarick MU, Espina B, Loureiro C, Bernstein-Singer M, Akil B, et al. Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Cancer 1990;5:1074-8.
12. Gill PS, Rarick M, McCutchan JA. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med 1991;90:427-33.
13. Zubrod CG, Schneiderman MA, Frei E. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of mitrogen mustard and triethylene thiophospho ramide. J Chron Dis 1960;11:7.
14. Mitsuyasu RT. Clinical variants and staging of Kaposi's Sarcoma. Semin Oncol 1987;14(2 Suppl):(3)13-8.
15. Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response and staging criteria. J Clin Oncol 1989;7(9):1201-7.
16. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
17. Hryniuk WM. The importance of dose intensity in the outcome of chemotherapy. In: De Vita VT, Hellman S, Rosenberg S, editors. Important advances in oncology. Philadelphia: JB Uppincott, 1988:121-41.
18. Kaplan EL, Meyer P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Armitage P, Berry G. Distribution-free methods. In: Armitage P, Berry G, Statistical methods in medical research. 2nd edition. London: Blackwell Scientific Publishers, 1987:408-20.
20. Chachoua A, Krigel R, Lafleur F. Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma. J Clin Oncol 1989;7(6):774-80.
21. Payne SF, Lemp GF, Rutherford GW. Survival following diagnosis of Kaposi's sarcoma for AIDS patients in San Francisco. J AIDS 1990;3(Suppl 1):514-7.